aDepartments of Surgery, New York University, New York, NY, USA bDepartment of Medicine, New York University, New York, NY, USA ...

DelveInsight's analysis shows that the UK reported the highest number of DED cases in individuals aged 50 and older, with ...

TuHURA Biosciences advances its phase 3 trial of IFx-2.0 for Merkel cell carcinoma, aiming to enhance immune response alongside pembrolizumab.

∥ University of Michigan Substance Abuse Research Center, Ann Arbor, Michigan Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across ...

Crystal structures of Aplysia AChBP bound with the agonist anabaseine, two partial agonists selectively activating the α7 receptor, 3‐(2,4‐dimethoxybenzylidene)‐anabaseine and its 4‐hydroxy metabolite ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes. (HealthDay News) — For adults with diabetes and obesity ...

today announced that it entered into an asset purchase agreement with Chase Therapeutics Corporation for a portfolio of potentially best-in-class dopamine agonist drug combinations, including ALTO ...

Cardiac metabolic dysfunction is a hallmark of heart failure (HF). Estrogen-related receptors ERRα and ERRγ are essential regulators of cardiac metabolism. Therefore, activation of ERR could be a ...

GLP-1 receptor agonists are a class of medication used to treat diabetes by helping control blood sugar. Some of these drugs are also approved to treat obesity. Little is known about how GLP-1 ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL. (HealthDay News) — For patients with overweight/obesity and/or diabetes ...